gohiam.com
NIDAnews
Edit

NIDAnews

https://nida.nih.gov/
Last activity: 21.08.2026
Active
Categories: DrugHealthTechMedtechPagePublicResearchScienceTraining
The National Institute on Drug Abuse's mission is to advance science of addiction
Website visits
2.5M /mo.
Mentions
120
Location: United States, Maryland, Bethesda
Employees: 201-500
Phone: +1 301-443-1124
Founded date: 1974

Mentions in press and media 120

DateTitleDescription
25.08.2026NIDA Grant Fuels PleoPharma's Groundbreaking Cannabis Addiction TreatmentPleoPharma secured a pivotal $6.5 million grant from the National Institute on Drug Abuse (NIDA). This funding accelerates its Phase 3 CAN-004 clinical trial. The trial investigates PP-01, a novel oral treatment for cannabis withdrawal symp...
21.08.2026PleoPharma Wins $6.5 Million NIDA Grant To Advance Phase 3 Cannabis Withdrawal TreatmentPleoPharma has received a $6.5 million, three-year grant from the National Institute on Drug Abuse to support its pivotal Phase 3 clinical program evaluating PP-01 as an investigational treatment for cannabis withdrawal symptoms in adults w...
20.08.2026PleoPharma Receives $6.5M NIDA GrantPleoPharma, a Phoenixville, PA-based clinical-stage development company focused on cannabis-related health issues, received a $6.5M grant from the National Institute on Drug Abuse (NIDA). The company intends to use the funds to support the ...
18.08.2026From Midlife to Later Life: Addressing the Intersection of Aging, Substance Use, and Mental Health in MenFor many men, midlife and the years that follow bring significant change — retirement, loss of a spouse or close friend, chronic pain, and changing hormones. These transitions can heighten vulnerability to depression, anxiety, and substance...
15.07.2026Ensysce Biosciences Awarded $5.3 Million To Advance Overdose-Protected OpioidEnsysce Biosciences has received a $5.3 million installment from the National Institute on Drug Abuse to support the development of its MPAR overdose-protection technology and lead product candidate, PF614-MPAR. The latest award represents ...
06.07.2026Naloxone and Other Opioid Overdose Reversal MedicationsOpioids are a class of drugs derived from substances found in the opium poppy plant. They can also be created synthetically. Examples of opioid drugs range from prescription pain medications to illegal, or illicitly manufactured, drugs. Opi...
25.06.2026PharmNovo reports broader therapeutic potential for PN6047PharmNovo reports broader therapeutic potential for PN6047 Thu, Jun 25, 2026 08:15 CET Report this content PharmNovo AB announces today new preclinical findings supporting the potential of PN6047 in migraine and opioid withdrawal syndrome. ...
17.06.2026‘PREPARE TO BE HELD ACCOUNTABLE’: GOV. DESANTIS SIGNS OFFICER JASON RAYNOR ACT, 4 OTHER CRIMINAL JUSTICE BILLSGov. Ron DeSantis has signed the “Officer Jason Raynor Act,” capping a three-year push by the families and colleagues of a lawman killed in the line of duty to ensure the outcome of his assailant’s case can never be repeated in a Florida co...
01.05.2026On National Fentanyl Awareness Day, DHS Thanks Customs and Border Protection for Stopping More Than 12,000 Pounds of Fentanyl from Flowing into American CommunitiesWASHINGTON –– The United States Department of Homeland Security (DHS) is observing National Fentanyl Awareness Day by remembering the lives that the illicit drug has destroyed and by honoring the men and women who are seizing this deadly po...
24.12.2025When should kids get a smartphone? A study links owning one before age 12 to health risksGetting your Trinity Audio player ready... By Kayla Yup, The Philadelphia Inquirer PHILADELPHIA — Ran Barzilay, a psychiatrist and researcher at Children’s Hospital of Philadelphia, won’t be letting his 9-year-old son get a smartphone befor...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In